Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Convertible Debt (2016 - 2017)

Lexaria Bioscience's Convertible Debt history spans 2 years, with the latest figure at $45000.0 for Q2 2017.

  • Quarterly results put Convertible Debt at $45000.0 for Q2 2017, changed 0.0% from a year ago — trailing twelve months through May 2017 was $45000.0 (changed 0.0% YoY), and the annual figure for FY2016 was $45000.0, changed.
  • Convertible Debt for Q2 2017 was $45000.0 at Lexaria Bioscience, roughly flat from $45000.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $45000.0 in Q2 2016 to a low of $45000.0 in Q2 2016.